Lansoprazole Delayed-Release Capsules — Class II drug recall D-0737-2022
Terminated recall by Dr. Reddy's Laboratories, Inc., reported 2022-04-06, distributed nationwide. Failed Dissolution Specifications; during long term stability testing.
| Recall number | D-0737-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Dr. Reddy's Laboratories, Inc., Princeton, NJ, United States |
| Recall initiated | 2022-03-23 |
| Classified | 2022-03-31 |
| Reported by FDA | 2022-04-06 |
| Terminated | 2024-02-02 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 55111-0398, 55111-0398-01, 55111-0398-05, 55111-0398-30, 55111-0398-60, 55111-0398-79, 55111-0398-90, 55111-0399, 55111-0399-01, 55111-0399-05, 55111-0399-30, 55111-0399-60, 55111-0399-79, 55111-0399-90 |
| Expiration dates | 2023-12 |
Product
Lansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-30), b) 90-count bottle, (55111-398-90), Rx Only, Manufactured. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090, India
Reason for recall
Failed Dissolution Specifications; during long term stability testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0737-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.